title: Treatment of telangiectasia: comparison of sclerosing agents.
abstract: A double-blind, double-paired comparison, placebo-controlled study was undertaken to determine the optimal agent for sclerotherapy of spider telangiectasias of the lower extremities. Sodium tetradecyl sulfate 0.5%, polidocanol 0.25%, heparsal, and normal saline control were evaluated in terms of clinical effectiveness and patient acceptance. Although all of the agents, except for the control, were effective, polidocanol was found to have the fewest adverse reactions and afforded the greatest patient comfort.
authors.affiliation: Department of Dermatology, Cleveland Clinic Foundation, Ohio.
authors.forename: M C
authors.initials: MC
authors.lastname: Carlin
authors.forename: J L
authors.initials: JL
authors.lastname: Ratz
mesh_terms: D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000627:therapeutic use; D012462:Saline Solution, Hypertonic / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000627:therapeutic use; D012981:Sodium Tetradecyl Sulfate / Q000627:therapeutic use; D013684:Telangiectasis / Q000628:therapy*
chemical_list: D012462:Saline Solution, Hypertonic; D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols; D012965:Sodium Chloride; D006493:Heparin; D012981:Sodium Tetradecyl Sulfate